Global Blood Pressure Monitors Pipeline Report 2022: Featuring Aktiia, AtCor Medical, Barron Associates and Blumio Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
'Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update'
This report provides comprehensive information about the Blood Pressure Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Blood Pressure Monitors includes blood pressure transducers that convert blood pressure into electrical signals and sphygmomanometers, a device consisting of a pressure gauge and a rubber cuff that wraps around the upper arm and wrist which inflates to constrict the arteries and measure the blood pressure.
Scope
Extensive coverage of the Blood Pressure Monitors under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Blood Pressure Monitors and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Blood Pressure Monitors under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Blood Pressure Monitors - Pipeline Products by Stage of Development
3.2 Blood Pressure Monitors - Pipeline Products by Segment
3.3 Blood Pressure Monitors - Pipeline Products by Territory
3.4 Blood Pressure Monitors - Pipeline Products by Regulatory Path
3.5 Blood Pressure Monitors - Pipeline Products by Estimated Approval Date
3.6 Blood Pressure Monitors - Ongoing Clinical Trials
4 Blood Pressure Monitors - Pipeline Products under Development by Companies
4.1 Blood Pressure Monitors Companies - Pipeline Products by Stage of Development
4.2 Blood Pressure Monitors - Pipeline Products by Stage of Development
5 Blood Pressure Monitors Companies and Product Overview
6 Blood Pressure Monitors- Recent Developments
7 Appendix
Companies Mentioned
Bold Diagnostics LLC
Cardian Ltd
CARDIOSIGN, INC.
Department of Biomedical Engineering Columbia University
Digitouch Health LLC
ImPress MedTech GmbH
Krisara Engineering, LLC
Pressao Medical
Shaare Zedek Medical Center
Shenzhen Shizhou Technology Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
The Chinese University of Hong Kong
For more information about this report visit https://www.researchandmarkets.com/r/2sl63v
Source: GlobalData
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.